News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,996 Results
Type
Article (49132)
Company Profile (305)
Press Release (688559)
Multimedia
Podcasts (76)
Webinars (13)
Section
Business (211536)
Career Advice (2111)
Deals (36446)
Drug Delivery (113)
Drug Development (83084)
Employer Resources (175)
FDA (16865)
Job Trends (15676)
News (357830)
Policy (34960)
Tag
Academia (2830)
Academic (2)
Accelerated approval (5)
Adcomms (22)
Allergies (90)
Alliances (51612)
ALS (95)
Alzheimer's disease (1439)
Antibody-drug conjugate (ADC) (143)
Approvals (16856)
Artificial intelligence (288)
Autoimmune disease (24)
Automation (16)
Bankruptcy (368)
Best Places to Work (12259)
BIOSECURE Act (20)
Biosimilars (114)
Biotechnology (203)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (299)
Cancer (2355)
Cardiovascular disease (190)
Career advice (1771)
Career pathing (30)
CAR-T (158)
Cell therapy (444)
Cervical cancer (21)
Clinical research (67519)
Collaboration (889)
Company closure (2)
Compensation (559)
Complete response letters (20)
COVID-19 (2776)
CRISPR (47)
C-suite (261)
Cystic fibrosis (105)
Data (2317)
Decentralized trials (2)
Denatured (28)
Depression (49)
Diabetes (288)
Diagnostics (6722)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (123)
Drug pricing (121)
Drug shortages (26)
Duchenne muscular dystrophy (99)
Earnings (88612)
Editorial (44)
Employer branding (22)
Employer resources (149)
Events (121036)
Executive appointments (769)
FDA (18269)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (810)
Gene editing (119)
Generative AI (26)
Gene therapy (327)
GLP-1 (767)
Government (4972)
Grass and pollen (5)
Guidances (150)
Healthcare (20304)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (130)
Indications (29)
Infectious disease (2934)
Inflammatory bowel disease (147)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (97)
Interviews (332)
IPO (16858)
IRA (44)
Job creations (3854)
Job search strategy (1504)
Kidney cancer (10)
Labor market (43)
Layoffs (497)
Leadership (17)
Legal (8465)
Liver cancer (79)
Lung cancer (327)
Lymphoma (156)
Machine learning (9)
Management (60)
Manufacturing (333)
MASH (78)
Medical device (14034)
Medtech (14039)
Mergers & acquisitions (20165)
Metabolic disorders (742)
Multiple sclerosis (85)
NASH (17)
Neurodegenerative disease (100)
Neuropsychiatric disorders (28)
Neuroscience (2011)
NextGen: Class of 2025 (7115)
Non-profit (4913)
Now hiring (40)
Obesity (397)
Opinion (230)
Ovarian cancer (81)
Pain (97)
Pancreatic cancer (90)
Parkinson's disease (155)
Partnered (21)
Patents (244)
Patient recruitment (116)
Peanut (47)
People (59889)
Pharmaceutical (74)
Pharmacy benefit managers (21)
Phase I (21104)
Phase II (29604)
Phase III (22075)
Pipeline (1355)
Policy (162)
Postmarket research (2760)
Preclinical (8980)
Press Release (71)
Prostate cancer (109)
Psychedelics (34)
Radiopharmaceuticals (258)
Rare diseases (405)
Real estate (6193)
Recruiting (66)
Regulatory (23741)
Reports (47)
Research institute (2531)
Resumes & cover letters (361)
Rett syndrome (5)
RNA editing (5)
RSV (46)
Schizophrenia (73)
Series A (140)
Series B (93)
Service/supplier (13)
Sickle cell disease (58)
Special edition (19)
Spinal muscular atrophy (153)
Sponsored (30)
Startups (3804)
State (2)
Stomach cancer (15)
Supply chain (73)
Tariffs (50)
The Weekly (46)
Vaccines (774)
Venture capitalists (42)
Weight loss (259)
Women's health (40)
Worklife (17)
Date
Today (165)
Last 7 days (953)
Last 30 days (3153)
Last 365 days (33541)
2025 (12103)
2024 (36411)
2023 (41347)
2022 (52602)
2021 (57322)
2020 (56299)
2019 (49437)
2018 (37431)
2017 (33561)
2016 (33633)
2015 (39690)
2014 (33357)
2013 (28362)
2012 (30555)
2011 (31217)
2010 (29446)
Location
Africa (839)
Alabama (58)
Alaska (7)
Arizona (251)
Arkansas (14)
Asia (40581)
Australia (6752)
California (6506)
Canada (2080)
China (547)
Colorado (279)
Connecticut (297)
Delaware (159)
Europe (88534)
Florida (960)
Georgia (224)
Hawaii (1)
Idaho (63)
Illinois (584)
India (26)
Indiana (330)
Iowa (11)
Japan (174)
Kansas (109)
Kentucky (26)
Louisiana (13)
Maine (70)
Maryland (961)
Massachusetts (4893)
Michigan (246)
Minnesota (422)
Mississippi (2)
Missouri (86)
Montana (29)
Nebraska (25)
Nevada (68)
New Hampshire (68)
New Jersey (1840)
New Mexico (28)
New York (1841)
North Carolina (1062)
North Dakota (8)
Northern California (2840)
Ohio (218)
Oklahoma (15)
Oregon (36)
Pennsylvania (1434)
Puerto Rico (13)
Rhode Island (33)
South America (1214)
South Carolina (26)
South Dakota (1)
Southern California (2456)
Tennessee (106)
Texas (965)
United States (24654)
Utah (195)
Virginia (159)
Washington D.C. (68)
Washington State (582)
West Virginia (3)
Wisconsin (66)
737,996 Results for "opko health inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results
May 1, 2025
·
11 min read
Press Releases
OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025
April 17, 2025
·
1 min read
GLP-1
OPKO and Entera Link Up to Advance First Oral GLP-1/Glucagon Drug Into Clinic
Under the terms of the agreement, OPKO will accept 60% of the development costs, while Entera will shoulder 40%.
March 18, 2025
·
2 min read
·
Tristan Manalac
Press Releases
OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results
February 28, 2025
·
12 min read
Press Releases
OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025
February 14, 2025
·
1 min read
BioMidwest
OPKO Health to Participate in the 2024 Jefferies Global Healthcare Conference
OPKO Health, Inc. announced that management will be participating in the Jefferies Global Healthcare Conference, being held June 4-6, 2024 at the Marriott Marquis in New York City.
May 31, 2024
·
1 min read
Press Releases
OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders
March 17, 2025
·
7 min read
Business
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
OPKO Health, Inc. reports business highlights and financial results for the three months ended March 31, 2024.
May 7, 2024
·
11 min read
Press Releases
OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 9, 2025
·
1 min read
Business
OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024
OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on Tuesday, May 7, 2024.
May 3, 2024
·
1 min read
1 of 73,800
Next
